Literature DB >> 19129265

Commentary: C-reactive protein and risk prediction--moving beyond associations to assessing predictive utility and clinical usefulness.

Ramachandran S Vasan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19129265      PMCID： PMC2639367          DOI： 10.1093/ije/dyn353

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN： 0300-5771            Impact factor:   7.196


× No keyword cloud information.
  15 in total

1.  A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives.

Authors:  Yoav Ben-Shlomo; Diana Kuh
Journal:  Int J Epidemiol       Date:  2002-04       Impact factor: 7.196

2.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 3.  Biomarkers of cardiovascular disease: molecular basis and practical considerations.

Authors:  Ramachandran S Vasan
Journal:  Circulation       Date:  2006-05-16       Impact factor: 29.690

4.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

Review 5.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

Review 6.  Atherothrombosis and high-risk plaque: part I: evolving concepts.

Authors:  Valentin Fuster; Pedro R Moreno; Zahi A Fayad; Roberto Corti; Juan J Badimon
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

7.  Use and misuse of the receiver operating characteristic curve in risk prediction.

Authors:  Nancy R Cook
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

8.  Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study.

Authors:  L Kuller; N Borhani; C Furberg; J Gardin; T Manolio; D O'Leary; B Psaty; J Robbins
Journal:  Am J Epidemiol       Date:  1994-06-15       Impact factor: 4.897

9.  Genetically elevated C-reactive protein and ischemic vascular disease.

Authors:  Jeppe Zacho; Anne Tybjaerg-Hansen; Jan Skov Jensen; Peer Grande; Henrik Sillesen; Børge G Nordestgaard
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

10.  C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study.

Authors:  Peter W F Wilson; Michael Pencina; Paul Jacques; Jacob Selhub; Ralph D'Agostino; Christopher J O'Donnell
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2008-11-09
View more
  1 in total

1.  Drug therapies for the primary prevention of cardiovascular events: trials and errors: 2009 Ancel Keys Memorial Lecture.

Authors:  Bruce M Psaty
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.